Company: HURA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0000950170-25-108972
Chunk: 1

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 1
Chunk 1
---
 and 75,000,000 shares authorized; 49,913,946 and 42,323,759 shares issued and outstanding as of June 30, 2025 and December 31, 2024.

     49,913

     42,324

     Additional paid in capital

     146,438,038

     125,397,691

     Accumulated deficit

     (127,316,953
     )

     (111,124,569
     )

     Total Stockholders' Equity

     19,449,528

     14,593,976

     Total Liabilities and Stockholders' Equity
      
     $
     34,621,304

     $
     19,966,684

The accompanying notes are an integral part of these condensed consolidated financial statements.